Mert Derya Güliz, Turgut Nergiz Hacer, Kelleci Meral, Semiz Murat
Department of Psychiatry, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey.
Department of Pharmacology, Faculty of Pharmacy, Cumhuriyet University, Sivas, Turkey.
Patient Prefer Adherence. 2015 Jan 13;9:87-93. doi: 10.2147/PPA.S75013. eCollection 2015.
This study was carried out to evaluate factors resulting in medication nonadherence within 6 months before admission to the psychiatric service of our hospital for bipolar disorder, schizophrenia/schizoaffective disorder, depression, and other psychiatric diseases.
Two hundred and three patients admitted to the Psychiatry Service of the Medical Faculty were included in this study. Sociodemographic parameters and clinical findings within 6 months before admission and patients' views on reasons of medication nonadherence were examined.
Patients were classified into four groups according to their diagnosis: bipolar disorder (n=68, 33.5%), schizophrenia/schizoaffective disorder (n=59, 29.1%), depression (n=39, 19.2%), and others (n=37, 18.2%). The ratio of medication nonadherence was higher in the bipolar disorder group when compared to the groups with schizophrenia/schizoaffective disorder, depression, and other disorders (12.1%, 18.2%, and 24.2% vs 45.5%); however, the ratio of medication nonadherence was similar in schizophrenia/schizoaffective disorder, depression, and the others group. In logistic regression analysis, irregular follow-up (odds ratio [OR]: 5.7; 95% confidence interval [CI]: 2.92-11.31) and diagnosis (OR: 1.5; 95% CI: 1.07-1.95) were determined to be important risk factors for medication nonadherence. The leading factors for medication nonadherence were: "not willing to use medication", "not accepting the disease", and "being disturbed by side effects" in the bipolar disorder group, "not accepting the disease" in the schizophrenia/schizoaffective disorder group, "feeling well" in the depression group, and "being disturbed by side effects" in the other diseases group.
Medication nonadherence is an important problem in psychiatric patients and should be dealt with by taking into account the diagnosis, attendance to follow-up appointments, and the patient's attitude. Ensuring regular attendance to follow-up appointments, adjusting the management plan according to the diagnosis, and improving their thoughts about resistance to medication can be beneficial in terms of medication adherence.
本研究旨在评估导致我院精神科收治的双相情感障碍、精神分裂症/分裂情感性障碍、抑郁症及其他精神疾病患者入院前6个月内药物治疗不依从的因素。
本研究纳入了医学院精神科收治的203例患者。研究考察了患者入院前6个月内的社会人口学参数和临床检查结果,以及患者对药物治疗不依从原因的看法。
根据诊断将患者分为四组:双相情感障碍组(n = 68,33.5%)、精神分裂症/分裂情感性障碍组(n = 59,29.1%)、抑郁症组(n = 39,19.2%)和其他组(n = 37,18.2%)。与精神分裂症/分裂情感性障碍组、抑郁症组及其他疾病组相比,双相情感障碍组的药物治疗不依从率更高(分别为12.1%、18.2%和24.2%,对比45.5%);然而,精神分裂症/分裂情感性障碍组、抑郁症组及其他组的药物治疗不依从率相似。在逻辑回归分析中,随访不规律(比值比[OR]:5.7;95%置信区间[CI]:2.92 - 11.31)和诊断(OR:1.5;95% CI:1.07 - 1.95)被确定为药物治疗不依从的重要危险因素。双相情感障碍组药物治疗不依从的主要因素为:“不愿用药”、“不接受疾病诊断”和“受副作用困扰”;精神分裂症/分裂情感性障碍组为“不接受疾病诊断”;抑郁症组为“感觉良好”;其他疾病组为“受副作用困扰”。
药物治疗不依从是精神科患者中的一个重要问题,应结合诊断、随访就诊情况及患者态度加以处理。确保定期随访就诊、根据诊断调整管理计划以及改善患者对药物抵抗的认知,可能有助于提高药物治疗依从性。